市场调查报告书
商品编码
1276567
皮肤消毒剂全球市场规模、份额和行业趋势分析报告:按类型、分销渠道、形式、地区、前景和预测,2023-2029 年Global Skin Antiseptic Market Size, Share & Industry Trends Analysis Report By Type (Alcohol, Chlorhexidine, Iodine), By Distribution Channel, By Form (Solutions, Swab Sticks, Cream), By Regional Outlook and Forecast, 2023 - 2029 |
到 2029 年,皮肤消毒剂市场规模预计将达到 25 亿美元,预测期内復合年增长率为 7.4%。
院内感染髮生率的增加是推动皮肤消毒剂需求的主要因素。 医疗保健中心的患者可能会感染导致这些疾病的细菌、病毒和其他病菌。 HAI 可引起范围广泛的疾病,从轻微到严重,有时甚至是致命的。 因此,医疗机构必须遵守严格的卫生标准,包括皮肤消毒剂,以预防 HAI。 此外,皮肤消毒剂对于降低侵入性操作(例如手术和其他医疗操作)后的感染风险很重要。
此外,已经证实,由于医疗费用飙升,全球防腐剂市场的增长率正在上升。 医疗保健部门的扩张更加强调提高护理标准和降低感染率。 因此,对防腐剂,尤其是皮肤防腐剂的需求不断增加。
COVID-19 影响分析
皮肤消毒剂现在在医疗机构之外使用,这对市场扩张产生了积极影响。 酒精含量较高的洗手液是用于皮肤消毒的皮肤消毒剂的主流。 它可以去除大多数细菌和病毒,而不仅仅是 COVID-19 病毒。 除了洗手液,还使用酒精湿巾、喷雾等皮肤消毒剂。 因此,大流行对市场扩张做出了积极贡献。
市场增长因素
交通事故增加
行人、骑自行车的人和骑摩托车的人占所有交通死亡人数的一半以上。 儘管拥有世界上约 60% 的汽车保有量,但中低收入国家仍占交通死亡人数的 93%。 随着道路交通伤害人数的增加,医疗保健专业人员面临着提供有效和及时护理的压力。 随着交通事故的增加,用于治疗伤口的皮肤消毒剂的需求也在增加。
HAI 发病率增加
不断增长的老年人口和糖尿病、心赃病、癌症、肥胖症和呼吸系统疾病等慢性病病例的增加是 HAI 增加的主要原因。 多年来,全世界进行的外科手术数量显着增加。 外科手术比例的增加增加了对各种手术器械和医疗器械的需求。 预计这会增加院内感染的发生率。 预计皮肤消毒剂市场将会增长,以避免对 HAI 的市场开发。
市场抑制因素
皮肤消毒剂的杀菌问题
固有污染髮生在製造过程中。 由于许多皮肤消毒剂都是水性的,这个问题影响所有水性製造商,除非产品经过灭菌或包装后灭菌。 因为很难也不可能从水系统中去除含有微生物的生物膜,所以这些微生物中的一些无疑会在製造过程中感染最终产品。 作为对策, "绝育" 很常见。 未来,皮肤消毒剂的问题可能会阻碍市场扩张。
输入 Outlook
按类型划分,皮肤消毒剂市场分为酒精、洗必太、碘和其他。 在 2022 年的皮肤消毒剂市场中,氯己定细分市场赢得了可观的收入份额。 皮肤感染用洗必泰(一种局部消毒剂)治疗。 它的作用是去除皮肤上的真菌和细菌。 因此,诸如疔疮、痤疮和湿疹之类的皮肤病经常使用此类药物进行治疗。 此外,这种物质用于消毒和清洁皮肤。 它还有助于防止皮肤刺激。
销售渠道前景
按分销渠道,皮肤消毒剂市场分为医院药房、在线供应商以及药店和零售药店。 2022 年,药店和零售药房细分市场主导了皮肤消毒剂市场,占据了最大的收入份额。 这主要是由于对门诊护理的需求增加以及对感染控制的影响的理解不断加深。 此外,皮肤消毒剂在这些商店的易得性也是支持该细分市场扩张的因素之一。
形态观
皮肤消毒剂市场按形式分为溶液、乳膏、药籤等。 到 2022 年,面霜部分将在皮肤消毒剂市场中占据重要的收入份额。 轻微烧伤、烧伤、割伤和擦伤、龟裂、晒伤、干燥、尿布疹、蚊虫叮咬、老年斑和丘疹可以用抗菌霜治疗,这些霜可以舒缓和治癒伤口,同时防止感染。 因此,面霜的易得性是促进生长的关键因素。
区域展望
按地区划分,我们对四个地区的皮肤消毒剂市场进行了分析:北美、欧洲、亚太地区和拉丁美洲/中东/非洲。 到 2022 年,亚太地区将在皮肤消毒剂市场占据重要的收入份额。 主要的市场驱动力之一是增加公共和私营部门的医疗保健支出。 由于这种情况,市场预计会增加,并有望吸引几家大型本地企业。
The Global Skin Antiseptic Market size is expected to reach $2.5 billion by 2029, rising at a market growth of 7.4% CAGR during the forecast period.
Skin antiseptics are compounds applied to the skin surface to eradicate or prevent the growth of germs. These substances are applied to the skin before surgical procedures to prevent infections. Skin antiseptics are crucial for maintaining a sterile environment when performing surgery or other invasive medical operations. The main goal of employing skin antiseptics is to lessen the number of bacteria on the skin's surface since these organisms might cause infections if they enter the body through a cut or other surgical invasion.
The danger of infections and the consequences they cause can be drastically decreased by healthcare professionals utilizing skin antiseptics. Also, there are numerous kinds of skin antiseptics available, including liquids, sprays, gels, and wipes. A wide variety of bacteria can be defeated by the active chemicals they contain. Povidone-iodine, chlorhexidine, and alcohol are the most often utilized active components in skin antiseptics.
The increased incidence of hospital-acquired infections is the primary factor driving the demand for skin antiseptics. Patients in a healthcare center can pick up bacteria, viruses, and other germs that cause these ailments. HAIs can result in various illnesses, from minor to serious, and can occasionally even result in death. Therefore, healthcare institutions must uphold strict hygiene standards, including skin antiseptics, to prevent HAIs. Skin antiseptics are furthermore crucial for lowering the risk of infection after intrusive treatments like surgeries and other medical procedures.
Moreover, a faster rate of growth in the antiseptic market has been observed globally due to rising healthcare costs. A greater emphasis is being placed on raising the standard of treatment and lowering infection rates as a result of the expanding healthcare sector. As a result, there is a rise in the demand for antiseptics, notably skin antiseptics.
COVID-19 Impact Analysis
The use of skin antiseptics extended outside of medical facilities, which had a favorable effect on the market expansion. The most popular skin antiseptics for skin disinfection are hand sanitizers having a significant proportion of alcohol content. They are capable of eliminating the COVID-19 virus as well as the majority of bacteria and viruses. Other skin antiseptics, like wipes and sprays with alcohol as an ingredient, are utilized in addition to hand sanitizers. Consequently, the pandemic contributed positively to market expansion.
Market Growth Factors
Rise in occurrence of road accidents
Pedestrians, bicyclists, and motorcyclists make up more than half of all road traffic fatalities. Despite the fact that low- and middle-income nations have about 60% of the world's vehicles, they account for 93% of all traffic deaths. Given the rise in traffic-related injuries, healthcare practitioners are under a lot of pressure to deliver effective and timely care. The need for skin antiseptics for wound care and other uses will increase along with traffic accidents.
Growing occurrence of HAI
The increase in the geriatric population, and the growth in cases of chronic conditions like diabetes, heart, cancer, obesity, and respiratory ailments are the leading causes of the rise in HAI. Over the years, the number of surgical operations carried out globally has risen significantly. The growing percentage of surgical operations has increased the demand for various surgical apparatus and medical devices. This is anticipated to increase the rate of hospital-acquired infections. In order to avoid the development of HAI, the market for cutaneous antiseptics is anticipated to expand.
Market Restraining Factors
Concerns regarding the sterilization of skin antiseptics
Intrinsic contamination happens throughout the manufacturing process. Since most skin antiseptics are water-based, this problem will affect all water-based manufacturers unless the product can be sterilized or is sterilized after packaging. Due to the difficulty or impossibility of removing biofilms containing microorganisms from water systems, some of these organisms will undoubtedly infect the finished product during production. The main remedy for this would seem straightforward: sterilize the finished item. Over the projected time, the problem with skin antiseptics may impede market expansion.
Type Outlook
Based on type, the skin antiseptic market is segmented into alcohol, chlorhexidine, iodine and others. The chlorhexidine segment acquired a significant revenue share in the skin antiseptic market in 2022. Skin infections are treated with chlorhexidine, a topical antiseptic. It operates by eliminating skin-based fungi and germs. Therefore, skin problems like boils, acne, and eczema are frequently treated with this kind of treatment. Moreover, this substance is utilized to sanitize and clean the skin. Also, it helps to avoid skin inflammation.
Distribution Channel Outlook
By distribution channel, the skin antiseptic market is bifurcated into hospital pharmacies, online providers, drug stores & retail pharmacies. In 2022, the drug stores & retail pharmacies segment dominated the skin antiseptic market with the maximum revenue share. It is primarily driven by the rising demand for outpatient treatments and the growing understanding of the significance of infection control. Additionally, the easy accessibility of skin antiseptics from these stores is one of the factors supporting market expansion in this segment.
Form Outlook
On the basis of form, the skin antiseptic market is fragmented into solutions, cream, swab sticks, and others. The cream segment covered a considerable revenue share in the skin antiseptic market in 2022. Minor burns and scalds, cuts & grazes, chapped skin, tiny areas of sunburn, dryness, diaper rash, bug bites, spots, and pimples can all be treated with antiseptic cream also soothes and cures wounds while preventing infection. The key component promoting the growth is the creams' simple availability.
Regional Outlook
Region wise, the skin antiseptic market is analyzed across North America, Europe, Asia Pacific and LAMEA. The Asia Pacific region garnered a significant revenue share in the skin antiseptic market in 2022. One of the main market drivers is the rise in healthcare spending in both the public and private sectors. The market is likely to increase as a result of this scenario, which is expected to attract several major and local businesses.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include XTTRIUM Laboratories, Sirmaxo Chemicals Private Limited, SCHULKE & Mayr GmbH, MOLNLYCKE Health Care (Investor AB), Cardinal Health, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, 3M Company, PDI Healthcare, Inc. and Ecolab, Inc.
Strategies deployed in Skin Antiseptic Market
Apr-2023: 3M Health Care launched the new FDA-approved 3M SoluPrep S Sterile Antiseptic Solution chlorhexidine gluconate (2% w/v) and isopropyl alcohol (70% v/v) Patient Preoperative Skin Preparation. The product has been shown to have fast-acting, broad-spectrum antibacterial action (in vitro; clinical significance unknown) and to persist in healthy human volunteers for at least 96 hours post-prep. 3M SoluPrep S Sterile Antiseptic Solution offers the efficacy healthcare professionals can rely on with the same active ingredients as the industry leader and additional benefits to help patients be protected. It is ideal for operating room nurses, doctors, and infection control professionals who want to prepare patient skin safely, effectively, and confidently before surgery to get rid of microorganisms on the skin that could potentially cause skin infections.
Jul-2022: Schulke Group took over Wet Wipes A/S, a market leader in surface wipes in the Scandinavian healthcare market. The acquisition complemented the company's product portfolio and would help in further expansion to the Scandinavian market.
Mar-2022: PDI Healthcare announced the dual launch of Sani-24® Germicidal Disposable Wipe, Sani-HyPerCide® Germicidal Spray, and Sani-HyPerCide® Germicidal Disposable Wipe, the novel, and innovative disinfectants. These products would help professionals in infection prevention in the fight against COVID-19 and healthcare-associated infections.
Mar-2022: Cardinal Health introduced the first surgical incise drape utilizing industry-leading antiseptic Chlorhexidine Gluconate (CHG). The drape has patented BeneHold CHG adhesive technology from Avery Dennison, which helps lower the risk of surgical site contamination with microorganisms that are frequently linked to surgical site infections (SSIs). The incise film offers a sterile surface to create a barrier to contamination and is sturdy, conformable, and breathable. Using CHG's antimicrobial characteristics in the surgical drape's adhesive is a novel strategy that aims to improve patient care by further lowering the risk of microbial contamination. CHG is a trusted topical antiseptic for surgical patient skin preparation.
Jan-2022: B. Braun opened a state-of-art Haemodialysis Concentrate Factory in the Thanh Oai Industrial Complex in Hanoi, Vietnam. With an initial investment of USD 5 million and a construction footprint of roughly 4000m2, the Haemodialysis Concentrate Factory enabled B. Braun Vietnam to supply the domestic and international markets with more than 2.5 million 10-litre canisters of hemodialysis each year. Additionally, it will make it possible for B. Braun Vietnam to continue serving the market and contribute to the daily protection and enhancement of the health of thousands of patients in Vietnam and all over the world.
Jun-2021: Schulke & Mayr GmbH announced an exclusive distribution agreement with Bactiguard for its wound care solutions' range to German hospitals. The agreement enabled Schulke to add Bactiguard's hypochlorous acid-based portfolio to its extensive line of antibacterial and wound care products.
Jul-2020: BD introduced the BD PurPrep patient preoperative skin preparation with a sterile solution. This solution is the first and single fully sterile povidone-iodine plus isopropyl alcohol single-use antiseptic skin preparation commercially accessible in the United States.
Market Segments covered in the Report:
By Type
By Distribution Channel
By Form
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures